臨床決策支援系統的全球市場 - 市場規模，佔有率，成長分析:各產品，各用途，各部署模式，各零件，產業預測(2022年～2028年)

Global Clinical Decision Support System Market Size, Share, Growth Analysis, By Product, By Application, By Deployment Mode, By Component - Industry Forecast 2022-2028

出版日期: 2023年04月28日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球臨床決策支援系統的市場規模在2021年估算為44億8,000萬美金，在預測期間(2023年～2030年)時預計將以10.4％的年複合成長率增長，從2022年的48億6,000萬美元到2030年達到107億美元。對與高質量醫療服務相結合的可靠技術解決方案的需求不斷增長是推動市場擴張的主要原因之一。隨著越來越多的醫院和醫療機構採用信息系統來幫助世界各地的政府開展工作，該行業也在不斷擴大。

本報告提供全球臨床決策支援系統市場相關調查分析，提供市場動態及預測，市場區隔分別分析，企業簡介等資訊。

市場概要
市場規模
市場動態
促進因素
機會
阻礙因素
課題
主要的市場洞察
技術分析
價格分析
供應鏈分析
價值鏈分析
市場生態系統
IP分析
貿易分析
Start-Ups分析
原料分析
革新矩陣
開發中產品分析
宏觀經濟指標
主要的投資分析
主要的成功因素
競爭的程度
市場動態及預測
市場動態
促進因素
機會
阻礙因素
課題
法規情形
波特的五力分析
有關未來的混亂的特別見解
政治影響
經濟影響
社會影響
技術性影響
環境的影響
法律上的影響

全球臨床決策支援系統市場:各產品

市場概要
獨立的CDSS
CDSS和整合的CPOE
CDSS和整合的EHR
CPOE·EHR和整合的CDSS

全球臨床決策支援系統市場:各用途

市場概要
藥物間相互作用
藥物過敏警報
臨床提醒
臨床指南
投藥支援
其他

全球臨床決策支援系統市場:各部署模式

市場概要
網站為基礎的系統
雲端基礎系統
內部部署系統

全球臨床決策支援系統市場:各零件

市場概要
硬體設備
軟體
服務

全球臨床決策支援系統市場規模:各地區

市場概要
北美
美國
加拿大
歐洲
德國
西班牙
法國
英國
其他的歐洲
亞太地區
中國
印度
日本
韓國
其他的亞太地區
南美
巴西
其他的南美
中東·非洲
GCC各國
南非
其他的中東·非洲

競爭情形

前五名公司的比較
主要企業的市場定位(2021年)
主要市場企業採用的策略
主要的成功策略
市場上最近的活動
主要企業的市場佔有率(2021年)

主要企業簡介

Wolters Kluwer Health(美國)
Hearst Health (美國)
Elsevier B.V. (荷蘭)
Cerner Corporation(美國)
McKesson Corporation (Change Healthcare)(美國)
Epic Systems Corporation(美國)
MEDITECH(美國)
Philips Healthcare(荷蘭)
International Business Machines (IBM) (美國)
Allscripts Healthcare Solutions, Inc.(美國)

簡介目錄

Product Code: SQSG45F2024

Global Clinical Decision Support System Market size was valued at USD 4.48 billion in 2021 and is poised to grow from USD 4.86 billion in 2022 to USD 10.7 billion by 2030, growing at a CAGR of 10.4% in the forecast period (2023-2030).

The increasing demand for trustworthy technology solutions that are integrated into high-quality care is one of the key reasons driving the market's expansion. As more hospitals and healthcare facilities deploy information systems, as well as helpful worldwide government activities, the industry is expanding. Clinical decision support systems are subject to stringent constraints imposed by authorities such as the FDA. Platforms that have been introduced or are currently in the development stage must therefore meet relevant FDA and CE Mark specifications. In order to maintain the integrity of their products, competitors must also ensure that information technology and cyber regulations are not broken.

CDSS companies and groups have taken steps to help curb the epidemic. CDSS has grown into a critical weapon in the fight against COVID-19, demonstrating how healthcare teams can stay up to current on the most recent COVID information and intelligence, hence improving the quality of treatment they provide. The Infectious Diseases Society of America advised repeating a COVID-19 test in people with a moderate to high risk. There was, however, no information on what factors made a patient more or less prone to contract the infection. An infectious disease team was always on duty at Massachusetts General Hospital. As a result, concentrated efforts led in the development of a CDS instrument known as COvid Risk cALculator (CORAL). The tool is embedded into the EHR. This should have a positive impact on market expansion. CORAL's outpatient version will be available in October 2021. CORAL is the first algorithm that has been integrated into ordinary, prospective physician workflow via an EHR CDSS and has retained its exclusivity.

The COVID-19 outbreak has put a strain on medical practises of all sizes, and healthcare facilities around the world are being overrun by the high number of people who attend them every day. The onset of this pandemic has increased need for precise diagnostic and therapeutic technologies in a number of countries worldwide. Clinical decision support systems have been shown to be useful in this regard since they allow healthcare professionals and organisations to monitor patients using a variety of equipment such as home blood pressure monitors and pulse oximeters. Furthermore, the disease's rapid global spread has resulted in a shortage of hospital beds and medical workers. This has boosted the demand for networked medical equipment for vital sign monitoring.

Furthermore, because of the pandemic, there was a larger need for social distance between doctors and patients, which increased demand for CDSS solutions and the timely and accurate transmission of patient health records. Many market participants have built COVID-19-related functionality into their existing EHRs, which are freely available to users.

Top-down and bottom-up approaches were used to estimate and validate the size of global Clinical Decision Support System Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report

Global Clinical Decision Support System Market is segmented based on Product, Application, Delivery Mode, Component, and Region. Based on Product the Clinical Decision Support System Market is further sub segmented into Standalone CDSS, Integrated CPOE with CDSS, Integrated E.H.R. with CDSS, Integrated CDSS with CPOE & E.H.R. Based on Application the Clinical Decision Support System Market is further sub segmented into Drug-drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines, Drug Dosing Support, Others , Based on Delivery Mode the Clinical Decision Support System Market is further sub segmented into Web-based Systems, Cloud-based Systems, On-premise Systems. Based on Component the Clinical Decision Support System Market is further sub segmented into Hardware, Software, Services. Based on Region the Clinical Decision Support System Market is further sub-segments into North America, Europe, Asia Pacific, Latin America, MEA.

Driver

The health ministers of the European Union agreed to collaborate to establish an eHealth common area in 2021, allowing for the free flow of electronic health records throughout the continent. The declaration also calls for eHealth to be included as a crucial component of the Europe 2021 agenda. Such policies/initiatives are projected to raise demand for and adoption of EHR, which will have an impact on CDSS adoption in key worldwide markets.

Restraints

Due to healthcare resources' aversion to installing and running clinical decision support systems, the worldwide clinical decision support systems market is projected to face growth obstacles.

Due to higher software installation and post-sale maintenance costs, the global market for clinical decision support systems is likely to face considerable growth limitations.

Market Trends

Partnerships between CDSS suppliers and hospitals have grown dramatically in the recent few years. The government's acknowledgment and initiatives to support the implementation of CDSS and EHR systems are projected to drive up demand even further. Integration with electronic health records (EHR) improves clinical care efficacy by reducing the amount of time spent seeking for a patient's medical history and records. Furthermore, the United States Government's Health and Medicare Acts have approved CDSS, financially rewarding CDS integration into EHRs (Electronic Health Records). In 2021, a CDSS was available in approximately 41% of American hospitals with an EHR, and a cutting-edge CDS was available in 40.2% of American hospitals. Furthermore, firms collaborate to develop and provide software that is up to date with the most recent data.